Sir Charles Gairdner

Nedlands 6009

1 studies enrolling now · 1 studies all time

What they study most

Hematologic Malignancy, Solid Malignancy

Studies at this site

• A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies — Enrolling by invitation